BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 35271501)

  • 1. The Critical Role of Therapeutic Plasma Exchange in the Treatment of MPO-ANCA Associated Crescentic IgA Nephropathy.
    Durmaz D; Anbarcioglu B; Bulut M; Erdogan B; Celik E; Akoglu H
    Iran J Kidney Dis; 2022 Jan; 1(1):63-65. PubMed ID: 35271501
    [TBL] [Abstract][Full Text] [Related]  

  • 2. ANCA-associated crescentic glomerulonephritis with mesangial IgA deposits.
    Haas M; Jafri J; Bartosh SM; Karp SL; Adler SG; Meehan SM
    Am J Kidney Dis; 2000 Oct; 36(4):709-18. PubMed ID: 11007672
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Simultaneous occurrence of diabetic glomerulosclerosis, IgA nephropathy, crescentic glomerulonephritis, and myeloperoxidase-antineutrophil cytoplasmic antibody seropositivity in a Chinese patient.
    Lui SL; Chan KW; Yip PS; Chan TM; Lai KN; Lo WK
    Am J Kidney Dis; 2002 Oct; 40(4):E14. PubMed ID: 12324935
    [TBL] [Abstract][Full Text] [Related]  

  • 4. ANCA and IgA glomerulonephritis all in one: prognosis and complications.
    Nissaisorakarn P; D'Agati V; Anis K; Jim B
    BMJ Case Rep; 2017 Oct; 2017():. PubMed ID: 29018146
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [IgA nephropathy with crescentic glomerulonephritis and ANCA positive].
    Ara J; Bonet J; Rodríguez R; Mirapeix E; Agraz I; Romero R
    Nefrologia; 2005; 25(6):712-7. PubMed ID: 16514914
    [TBL] [Abstract][Full Text] [Related]  

  • 6. High-frequency plasma exchange therapy for immunocompromised, type I crescentic glomerulonephritis complicated with IgA nephropathy: A case report and literature review.
    Chen H; Jin J; Cheng MJ; He L; Zhou W; Guo L; Niu ZZ; Liang XN; Zhu RF; Bai Y; Xu JS
    Medicine (Baltimore); 2023 Jan; 102(3):e32698. PubMed ID: 36701698
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Patient with MPO-ANCA-positive IgA Nephropathy Diagnosed with the Clinical Onset of Macrohematuria.
    Yasukawa M; Kitagawa S; Togashi R; Asakawa S; Nagura M; Arai S; Yamazaki O; Tamura Y; Kondo F; Ohashi R; Uchida S; Shibata S; Fujigaki Y
    Intern Med; 2019 Jul; 58(14):2051-2056. PubMed ID: 30918194
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Case of rapidly progressive glomerulonephritis with anti-glomerular basement membrane antibody in the course of MPO-ANCA-associated pachymeningitis].
    Yamazaki C; Arai S; Tamura Y; Suzuki Y; Nakajima H; Kojima K; Uchida S
    Nihon Jinzo Gakkai Shi; 2009; 51(4):490-5. PubMed ID: 19601559
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Report on intensive treatment of extracapillary glomerulonephritis with focus on crescentic IgA nephropathy.
    Roccatello D; Ferro M; Coppo R; Giraudo G; Quattrocchio G; Piccoli G
    Nephrol Dial Transplant; 1995 Nov; 10(11):2054-9. PubMed ID: 8643167
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A case of necrotizing crescentic glomerulonephritis in which myeloperoxidase antineutrophil cytoplasmic antibodies (ANCA) reflect the disease activity and recognize various neutrophil cytoplasmic constituents].
    Fujimoto T; Kimura A; Ameno M; Shiiki H; Dohi K
    Nihon Jinzo Gakkai Shi; 1997 Mar; 39(2):172-7. PubMed ID: 9134836
    [TBL] [Abstract][Full Text] [Related]  

  • 11. ANCA-related crescentic glomerulonephritis in systemic sclerosis: revisiting the "normotensive scleroderma renal crisis".
    Arnaud L; Huart A; Plaisier E; Francois H; Mougenot B; Tiev K; Kettaneh A; Ronco P; Rougier JP
    Clin Nephrol; 2007 Sep; 68(3):165-70. PubMed ID: 17915619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myeloperoxidase-antineutrophil cytoplasmic antibody causes different renal diseases by immune-complex formation and pauci-immune mechanism: A case report.
    Manabe S; Hatano M; Nakano M; Fujii T; Nitta K; Nagata M
    Pathol Int; 2017 Aug; 67(8):419-424. PubMed ID: 28580649
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A pediatric occurrence of crescentic glomerulonephritis associated with antineutrophil cytoplasmic antibodies and mesangial IgA deposits.
    Jimbo R; Ubara Y; Tagami T; Higa Y; Suwabe T; Nakanishi S; Sogawa Y; Nomura K; Kadoguchi H; Hoshino J; Sawa N; Katori H; Takemoto F; Hara S; Hara S; Ohashi K; Takaichi K
    Clin Nephrol; 2007 Aug; 68(2):104-8. PubMed ID: 17722710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antineutrophil cytoplasmic autoantibody-associated rapidly progressive glomerulonephritis in a patient with primary biliary cirrhosis.
    Nakamura T; Kawagoe Y; Ueda Y; Koide H
    Am J Med Sci; 2004 Sep; 328(3):176-9. PubMed ID: 15367878
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Focal segmental glomerulosclerosis after renal transplantation in a child with ANCA-associated glomerulonephritis: case report and literature review].
    Rong LP; Chen LZ; Fu Q; Chen WF; Sun LZ; Jiang XY; Mo Y
    Zhonghua Er Ke Za Zhi; 2016 Dec; 54(12):936-940. PubMed ID: 27938596
    [No Abstract]   [Full Text] [Related]  

  • 16. [Case of immune complex crescentic glomerulonephritis with consistently high titers of MPO-ANCA for 6 years].
    Ayada M; Matsuo T; Takada S; Kusaura T; Suda S; Okado T; Mori Y; Tajima M; Kuwahara M; Kobayashi Y; Tsukamoto Y; Sasaki S
    Nihon Jinzo Gakkai Shi; 2007; 49(5):511-6. PubMed ID: 17695814
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Retrospective study of primary IgA nephropathy with crescent formation and/or rapidly progressive glomerulonephritis in children].
    Wang D; Wang F; Ding J; Xiao H; Zhong X; Liu X
    Zhonghua Er Ke Za Zhi; 2015 Sep; 53(9):670-5. PubMed ID: 26757967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. ANCA-positive glomerulonephritis and IgA nephropathy in a patient on propylthiouracil.
    Winters MJ; Hurley RM; Lirenman DS
    Pediatr Nephrol; 2002 Apr; 17(4):257-60. PubMed ID: 11956877
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Is presence of ANCA in crescentic IgA nephropathy a coincidence or novel clinical entity? A case series.
    Bantis C; Stangou M; Schlaugat C; Alexopoulos E; Pantzaki A; Memmos D; Ivens K; Heering PJ
    Am J Kidney Dis; 2010 Feb; 55(2):259-68. PubMed ID: 20042261
    [TBL] [Abstract][Full Text] [Related]  

  • 20. MPO-ANCA-positive anti-glomerular basement membrane antibody disease successfully treated by plasma exchange and immunosuppressive therapy.
    Murakami T; Nagai K; Matsuura M; Kondo N; Kishi S; Araoka T; Kishi F; Sakiyama T; Mima A; Bando Y; Abe H; Doi T
    Ren Fail; 2011; 33(6):626-31. PubMed ID: 21599422
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.